Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A budget calculator informs decisions by translating income and expenses into actionable insights. Learn how to apply results to smarter financial moves.
19,592 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
As mega-cap tech pours capital into AI, investors seek signs of durable returns. This piece analyzes which firms stan...
A new study ties ethical leadership to stronger profits, showing that business, nice guys finish when firms prioritiz...
A big stock move and a buyout rumor are reshaping how traders view NCR Atleos. A large block sale drew attention, jus...
The S&P 500 dropped around 1.5% as crude surged on geopolitical worries, reviving inflation fears and tempering expec...
Micron rode a wave of AI demand to notable gains. This guide breaks down whether that momentum can persist into 2026 ...
UniCredit announces a $40 billion bid for Germany’s second-largest bank with a 4% premium, but early signals point to...
Bridgewater founder Ray Dalio warns a brutal ‘final’ clash at the Strait of Hormuz could decide whether the U.S.-led ...
WM Technology MAPS is weighing a pivotal year. This guide breaks down the Q4 2025 earnings, what technology (maps) 20...
Starbucks shares have slipped sharply in a single week. This guide breaks down what’s driving the move, how to assess...
Federal bank regulators announced a three-part plan to revise capital rules for mortgage assets, aiming to lift origi...
Markets move on news that the U.S. DEA has designated Colombia's president as a priority target in an ongoing probe. ...